Developing a structured and rigorous peer-review quality assurance process that involves ongoing case presentations, open discussion, and consensus opinions can help to decrease perception errors and improve the interpretive skills of breast imagers, according to radiologists at Beth Israel Deaconess Medical Center in Boston.
Developing a structured and rigorous peer-review quality assurance process that involves ongoing case presentations, open discussion, and consensus opinions can help to decrease perception errors and improve the interpretive skills of breast imagers, according to radiologists at Beth Israel Deaconess Medical Center in Boston.
"Between 10% and 30% of breast cancers are missed on mammography, and up to half of all cancers are identified retrospectively on a prior screening mammogram," said Dr. Valerie Fein-Zachary, radiologist and the principal author of an education exhibit presented at RSNA 2009. "To reduce errors of perception and interpretation, we must increase our understanding of why these errors occur."
The identification of a missed breast cancer is subjective and controversial. She defines a missed breast cancer as a subset of false-negative cases where a consensus of reviewers in a well-organized QA environment identifies a suspicious finding on imaging (mammogram, ultrasound, or MRI). She defines interval cancers as those occurring within one year of a negative breast imaging examination.
Beth Israel Deaconess has six ways of collecting possible cases of missed breast cancer:
All successful QA programs have a designated QA radiologist, Fein-Zachary said. The QA breast radiologist collects the data and cases for QA presentations, including missed breast cancers. The person is trusted to maintain confidentiality, and every month or two, four to six cases are presented to the breast imagers for review, including at least one "normal" case. The presentation of the cases includes the target exam and a comparison, if available. It may also include subsequent follow-up studies.
The breast imagers, fellows, and senior residents complete evaluation sheets, with exam dates and breast peer-review QA codes for each study. The group has one minute to evaluate each study, and the presenter continues through the sequence, providing appropriate history. A radiologist highlights the main teaching points, and a consensus is reached.
"The educational value of discussing missed breast cancers in a confidential, nonthreatening environment with staff, fellows, and residents cannot be overstated," she said. "Done properly, we have found no problem with the two major traditional challenges to QA programs: the fear of legal repercussions and the difficulty of discussing personal errors in a group setting."
Although cases under discussion are anonymous and remote, some radiologists appreciated prior notification of cases in which they were involved, she said. Lectures with legal and risk management departments also help to alleviate tensions.
Fein-Zachary acknowledges that the major impediment to instituting this type of breast peer-review QA process is time. To create a meaningful teaching experience, the QA radiologists must review cases and prepare them in advance. Consensus peer-review requires at least three radiologists, which may not be feasible in smaller practices. A more practical method of identifying missed cancers may be to cross-reference the database of breast imaging patients with state-wide cancer registries, she said. This would be particularly helpful for practices without electronic medical records or where surgical follow-up is not at the same institution.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,00 women with no prior history of breast cancer.
Comparing Digital Breast Tomosynthesis to Digital Mammography: What a Long-Term Study Reveals
September 17th 2024In a study involving over 272,000 breast cancer screening exams, digital breast tomosynthesis (DBT) had a higher breast cancer detection rate and a lower rate of advanced cancer presentation at the time of diagnosis in comparison to digital mammography.
Mammography Study: Can Stand-Alone AI Enhance Detection of Interval Breast Cancer?
August 28th 2024Identifying over 23 percent of interval breast cancers with a 96 percent sensitivity in mammography interpretation, an emerging AI software also facilitated correct localization in over 75 percent of cases involving interval breast cancer, according to new research.